Ischaemic and non-ischaemic cardiomyopathies - cardiac MRI appearances with delayed enhancement

被引:44
作者
Jackson, E.
Bellenger, N.
Seddon, M.
Harden, S.
Peebles, C.
机构
[1] Southampton Gen Hosp, Dept Cardiothorac Radiol, Southampton SO16 6YD, Hants, England
[2] Southampton Gen Hosp, Dept Cardiol, Southampton SO16 6YD, Hants, England
关键词
CARDIOVASCULAR MAGNETIC-RESONANCE; MYOCARDIAL VIABILITY; HYPERTROPHIC CARDIOMYOPATHY; CONTRAST ENHANCEMENT; IMAGING TECHNIQUE; INFARCTION; RECOVERY; DYSFUNCTION; INJURY; REVASCULARIZATION;
D O I
10.1016/j.crad.2006.11.013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
Over the past few years, cardiovascular magnetic resonance (CMR) imaging has rapidly developed and is now a robust clinical tool capable of providing high-resolution images of the heart in any desired plane. Delayed contrast-enhanced CMR (DE-CMR) can be used for non-invasive tissue characterization, with differing patterns of hyperenhancement displayed by ischaemic and non-ischaemic cardiomyopathies. This review explains the theory behind delayed hyperenhancement, and demonstrates the potential of DE-CMR in the diagnosis of a wide range of different cardiac disease states. (c) 2006 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 45 条
[1]
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis [J].
Allman, KC ;
Shaw, LJ ;
Hachamovitch, R ;
Udelson, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1151-1158
[2]
[Anonymous], J CARDIOVASC MAGN RE
[3]
Barkhausen J, 2002, RADIOLOGY, V225, P626
[4]
Bellenger Nick, 2006, EuroIntervention, V1, P445
[5]
Use of inversion recovery contrast-enhanced MRI for cardiac imaging: Spectrum of applications [J].
Bogaert, J ;
Taylor, AM ;
Van Kerkhove, F ;
Dymarkowski, S .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 182 (03) :609-615
[6]
Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. [J].
Bogaert, J ;
Goldstein, M ;
Tannouri, F ;
Golzarian, J ;
Dymarkowski, S .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (04) :981-985
[7]
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy [J].
Choudhury, L ;
Mahrholdt, H ;
Wagner, A ;
Choi, KM ;
Elliott, MD ;
Klocke, FJ ;
Bonow, RO ;
Judd, RM ;
Kim, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) :2156-2164
[8]
MR perfusion and delayed enhancement imaging in the heart [J].
Crean, A ;
Merchant, N .
CLINICAL RADIOLOGY, 2006, 61 (03) :225-236
[9]
Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction [J].
Dendale, P ;
Franken, PR ;
Block, P ;
Pratikakis, Y ;
De Roos, A .
AMERICAN HEART JOURNAL, 1998, 135 (05) :875-880
[10]
Cardiac sarcoidosis [J].
Doughan, AR ;
Williams, BR .
HEART, 2006, 92 (02) :282-288